Santhera Pharmaceuticals Holding AG (SWX: SANN)

SANN Revenue

Santhera Pharmaceuticals Holding AG had revenue of 39.09M CHF in the half year ending June 30, 2023, a decrease of -31.05%. This brings the company's revenue in the last twelve months to 81.11M, down -11.34% year-over-year. In the fiscal year ending June 30, 2023, Santhera Pharmaceuticals Holding AG had annual revenue of 81.40M, down -13.43%.

• Revenue (ttm): 81.11M
• Revenue Growth: -11.34%
• P/S Ratio: 0.95
• Revenue / Employee: 2.30M
• Employees: 45
• Market Cap: 108.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	81.40M	-12.62M	-13.43%
Jun 30, 2022	94.02M	-15.24M	-13.95%
Jun 30, 2021	109.26M	5.60M	5.41%
Jun 30, 2020	103.66M	1.75M	1.71%
Jun 30, 2019	101.91M	14.77M	16.95%